Where does Fate Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Fate Therapeutics, Inc. ranks #7,002 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Fate Therapeutics, Inc. hold?

Fate Therapeutics, Inc. holds 47 US utility patents granted between 2016 and 2025, spanning 8 technology areas.

What is Fate Therapeutics, Inc.'s Innovation Score?

Fate Therapeutics, Inc. has an Innovation Score of 41.2 out of 100 (top 34% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Fate Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Fate Therapeutics, Inc.'s recent grant velocity is +160% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Fate Therapeutics, Inc.'s patents?

Fate Therapeutics, Inc.'s patents average 21.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Fate Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Fate Therapeutics, Inc.

Q: What technology areas does Fate Therapeutics, Inc. focus on?

Fate Therapeutics, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 41 patents, ranking #251 of 4,144 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 47 granted patents across 8 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Fate ranks #7,002 of 49,997 tracked US assignees by granted-patent volume, with 47 patents across 8 technology areas.

#7,002
of 49,997 US assignees by volume: Top 34%
by Innovation Score (41.2/100): 21.4
avg claims per patent: +160%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7002 · US Corporation #7,002 · 47 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 47 grants
UPPER-Q #7,002/49,997
PHOTO-FINISH Delta Int'l…
CPC-NARROW C12N · 8 areas
INNOV-PAR 41.2/100
CLAIMS-DENSE 21.4 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +160% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Delta Electronics Int'l (Singapore) Pte Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Fate’s 41.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.4 pts (32%) Velocity 5.0 pts (12%) Breadth 10.0 pts (24%) Claim depth 12.9 pts (31%)

Qualcomm Incorporated · highest

85
ExtraHop Networks · near

41
Fate Therapeutics · this assignee

41
Honeybee Robotics · near

41
NEW Century Products · near

41
PN II · near

41
3D Lighting… · lowest

7

What this shows Fate's Innovation Score is 41.2/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Fate?

Each dot is one of Fate’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Fate’s own 21.4 claims/patent is ABOVE the 16.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Fate vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Fate's grants concentrate

Fate Therapeutics, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 87.2% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2021 (10 grants) versus a trough of 1 in 2017. By volume, Fate sits between Delta Electronics Int'l (Singapore) Pte Ltd and Guangzhou Issyzone Technology Co., Limited.

Fate's three-year grant acceleration

Fate Therapeutics, Inc. shows 12 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Delta Int'l (Sing…

47
Elbit Systems OF…

47
Embarcadero

47
Endologix

47
Flotek Chemistry

47
General Electric…

47
Grains Research A…

47
Guangzhou Issyzon…

47
Fate Therapeutics ◀

47

What this shows Fate holds 47 patents at rank #7,002, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Fate

By rank, the assignees closest to #7,002 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Fate's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Fate, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Fate ranks #251 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

ExtraHop Networks, Inc. 41 PN II, Inc. 41 NEW Century Products Co., Ltd. 41 Honeybee Robotics, LLC 41

Fate's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Fate Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	3	6.4%
2017	1	2.1%
2018	4	8.5%
2019	2	4.3%
2020	4	8.5%
2021	10	21.3%
2022	5	10.6%
2023	3	6.4%
2024	4	8.5%
2025partial year	11	23.4%

Which technologies does Fate Therapeutics, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 41

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 37

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 34

C07K - Peptides 22

Y02A - Technologies FOR Adaptation TO Climate Change 14

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Fate Therapeutics, Inc.'s patent record in context - here's where to go next.

Fate Therapeutics, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 87.2% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #7,002 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Fate Therapeutics, Inc. against Delta Electronics Int'l (Singapore) Pte Ltd, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.